Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus

Allogeneic mesenchymal stem cell (MSC) transplantation has recently become a promising therapy for patients with systemic lupus erythematosus (SLE). MSCs are a kind of multipotent stem cell than can efficiently modulate both innate and adaptive immune responses, yet those from SLE patients themselve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yantong, Feng, Xuebing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968462/
https://www.ncbi.nlm.nih.gov/pubmed/29793537
http://dx.doi.org/10.1186/s13287-018-0898-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968462/
https://www.ncbi.nlm.nih.gov/pubmed/29793537
http://dx.doi.org/10.1186/s13287-018-0898-x

Ejemplares similares